Atavistik Bio
Precision allosteric therapeutics inspired by the body’s natural regulators
42 employees · est. 2021 · Cambridge, United States
Incyclix Bio is the older company (2021 vs 2020).
Side-by-Side Comparison
| Metric | Atavistik Bio | Incyclix Bio |
|---|---|---|
| Founded | ||
| Founded | 2021 | 2020 older |
| Headquarters | ||
| Headquarters | Cambridge, United States | Durham, United States |
| Employees | ||
| Employees | 42 | 13 |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Series B | Series B |
| Total Funding | ||
| Total Funding | $260.00M | $64.00M |
| Funding Rounds | ||
| Funding Rounds | 5 | 5 |
| Services | ||
| Services | Not tracked yet | Development of selective CDK inhibitors, Clinical development of INX-315, Research and discovery in oncology |
| Target Customers | ||
| Target Customers | Not tracked yet | Cancer patients, Healthcare professionals, Oncologists, Biotech investors, Pharmaceutical researchers |
| Taxonomy | ||
| Taxonomy | Drug Discovery, Metabolism, Allosteric Precision Therapeutics, Biological Regulators, Proprietary Screening Technology, AI-enabled Drug Discovery Platform, Novel Allosteric Sites, Protein Targets, RNA Targets, Structural Insights, Small Molecule Therapeutics Design | Cell Cycle Control, Precision Treatments, CDK2 Inhibitor, Cancer Therapeutics, Small Molecule Inhibitors, Oncology Drug Development, Cyclin-Dependent Kinases, Tumor Types, Ovarian Cancer, Breast Cancer, Lung Cancer, Clinical Stage Biotechnology, Aberrant Proliferation, Drug Discovery, Research Triangle Park |
| Website | ||
| Website | atavistikbio.com | incyclixbio.com |
About Atavistik Bio
Atavistik Bio is a biotechnology startup that focuses on drug discovery inspired by metabolism. The company's proprietary screening technology, which utilizes the body's natural regulators, combined with an AI-enabled drug discovery platform, enables the identification of novel allosteric sites for...
About Incyclix Bio
Incyclix Bio, a pioneer founded in 2020, is at the forefront of biotechnology innovation with its next-generation approach in cell cycle control. Under the slogan "Regaining Cell Cycle Control", the company is committed to developing precision treatments targeting the aberrant proliferation that is...
We will tell you when either one moves
BounceWatch watches Atavistik Bio and Incyclix Bio for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Atavistik Bio and Incyclix Bio — by email.
Frequently Asked Questions
Compare Atavistik Bio with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Atavistik Bio on 9 Jun 2026, and Incyclix Bio on 4 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.